PT Siloam International Hospitals Tbk
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PT Siloam International Hospitals Tbk - overview
Established
1996
Location
-, -, Indonesia
Primary Industry
Healthcare
About
PT Siloam International Hospitals Tbk, based in Indonesia, operates as a premier private healthcare provider, delivering extensive medical services aimed at improving patient health outcomes across the nation. Founded in 1996 and headquartered in Banten, Indonesia, PT Siloam International Hospitals Tbk specializes in private healthcare services. In May 2024, Sight Investment Company Pte. Ltd.
agreed to acquire a 45% minority stake in PT Siloam International Hospitals Tbk from PT Lippo Karawaci Tbk and Gateway Partners for approximately IDR 16. 7 trillion or IDR 2,850 apiece. The transaction was completed in September 2024. The company is led by a team of CEOs including Caroline Riady, Irwan Gandana, and Lily Winata.
Siloam Hospitals operates as a leading private healthcare provider in Indonesia, offering a comprehensive range of medical services designed to address various health challenges. Their core offerings include specialized care in areas such as obstetrics, nephrology, cardiology, neurosurgery, oncology, urology, orthopedics, and digestive health. Each of these services is tailored to meet the needs of diverse patient demographics, with a focus on delivering high-quality medical care through advanced procedures and technologies. The hospitals cater to patients from various socio-economic backgrounds and are strategically located across Indonesia, ensuring accessibility for a wide client base.
Siloam Hospitals has established a reputation by managing over 200 in-vitro fertilization (IVF) births, conducting more than 3,700 cardiac procedures, and performing a multitude of surgeries across different specialties annually. In 2023, Siloam Hospitals reported a revenue of IDR 11,190,511,000 with an EBITDA of IDR 1,758,159,000,000. The company generates revenue through a multifaceted business model that includes direct-to-consumer healthcare services, partnerships with insurance providers, and collaborations with corporate entities for employee health programs. Patients secure appointments for a range of services from consultations to surgical interventions, often covered by health insurance plans.
Siloam Hospitals' extensive offerings encompass flagship services such as IVF treatments, kidney transplants, and cardiac procedures, which contribute to their revenue streams. Following the recent acquisition deal on May 13, 2024, Siloam Hospitals plans to utilize the raised funds to expand their healthcare services and enhance operational efficiencies. The company aims to design and launch new medical products tailored to emerging health needs while strategically expanding into additional markets within Southeast Asia by 2025.
Current Investors
Temasek Holdings, GIC, CVC
Primary Industry
Healthcare
Sub Industries
Hospitals, Cardiology, Chiropractic, Orthopedic & Physical Therapy, Oncology/Cancer Treatment
Website
www.siloamhospitals.com
Verticals
HealthTech
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
PT Siloam International Hospitals Tbk - timeline of key events
PT Siloam International Hospitals Tbk - financials
| Fiscal Year Ended | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 2,503,599,992,916 | - | 4,144,118,302,585 | 4,144,118,302,585 | 5,848,006,000,000 | 5,964,650,000,000 | 7,017,919,000,000 | 7,110,124,000,000 | 9,381,891,000,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | 41.1% | 2.0% | 17.7% | 1.3% | 32.0% | - | - | - |
| EBITDA (USD) | 131,166,043,979 | - | 259,724,802,037 | 174,615,314,292 | 356,740,000,000 | 399,911,000,000 | 140,261,000,000 | 840,695,000,000 | 1,738,226,000,000 | - | - | - |
| Operating Income (USD) | 78,684,797,327 | - | 158,065,689,443 | 158,065,689,443 | 219,288,000,000 | 191,652,000,000 | (100,272,000,000) | 390,592,000,000 | 1,018,703,000,000 | - | - | - |
| Operating Margin | 3.1% | - | 3.8% | 3.8% | 3.7% | 3.2% | (1.4%) | 5.5% | 10.9% | - | - | - |
| % EBITDA Margin | 5.2% | - | 6.3% | 4.2% | 6.1% | 6.7% | 2.0% | 11.8% | 18.5% | - | - | - |
| NET Income (USD) | 50,192,486,904 | - | 61,706,076,528 | 61,706,076,528 | 103,521,000,000 | 26,393,000,000 | (332,998,000,000) | 125,250,000,000 | 700,184,000,000 | - | - | - |
| % Net Margin | 2.0% | - | 1.5% | 1.5% | 1.8% | 0.4% | (4.7%) | 1.8% | 7.5% | - | - | - |
PT Siloam International Hospitals Tbk - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LP Direct, Trade Sale | Completed | PT Siloam International Hospitals Tbk | - | ||||||||
| PIPE | Completed | PT Siloam International Hospitals Tbk | - | ||||||||
| Seed | Completed | PT Pintar Data Group | - | ||||||||
| Trade Sale | Completed | RSUPB Hospital | - | ||||||||
| Trade Sale | Completed | Sentosa Hospital | - |
Displaying 1 - 5 of 7
PT Siloam International Hospitals Tbk - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.